<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01225003</url>
  </required_header>
  <id_info>
    <org_study_id>S52302</org_study_id>
    <nct_id>NCT01225003</nct_id>
  </id_info>
  <brief_title>Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas</brief_title>
  <official_title>Diffusion Kurtosis Imaging en MR Spectroscopy in Grading and the Characterization of Tumour Infiltration in Gliomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <brief_summary>
    <textblock>
      In this study, we evaluate the role of diffusion kurtosis imaging (DKI) and MR spectroscopy&#xD;
      (MRS), two advanced imaging techniques in magnetic resonance (MR) in grading and detection of&#xD;
      microscopic infiltrating tumour in gliomas. These parameters are of utmost importance in&#xD;
      optimal choice and planning of treatment.&#xD;
&#xD;
      Patients treated with gliomatous brain tumours are included voluntarily. They undergo one&#xD;
      imaging session on a 3T MR scanner prior to treatment.&#xD;
&#xD;
      DKI data are quantitively analyzed in order to estimate specific parameters in normal&#xD;
      appearing white matter, grey matter, tumor and peritumoral edema. MRS data are analyzed&#xD;
      quantitatively and qualitatively with peak integration, ratio calculation and classification&#xD;
      algorithms. Histological confirmation is obtained at subsequent surgery.&#xD;
&#xD;
      Information from this study can be of significant importance in avoiding brain biopsies.&#xD;
      Furthermore, information on microscopic tumour spread can be used during neurosurgery or in&#xD;
      radiotherapy planning. An important advantage of these advanced MR techniques is the&#xD;
      non-invasivity and the lack of ionizing radiation, two important issues in this relatively&#xD;
      young patient population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gliomas</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      standard neurosurgical procedure to obtain specimens; standard histopathological examination&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients diagnosed with a gliomatuous brain tumor, prior to treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of gliomatous brain tumour&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  younger than 18 years of age&#xD;
&#xD;
          -  prior treatment&#xD;
&#xD;
          -  history of neurological or neurosurgical treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Sunaert, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uwe Himmelreich, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic University Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals of Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3001</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <study_first_submitted>October 19, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>September 28, 2011</last_update_submitted>
  <last_update_submitted_qc>September 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gliomas</keyword>
  <keyword>magnetic resonance</keyword>
  <keyword>diffusion kurtosis imaging</keyword>
  <keyword>MR spectroscopy</keyword>
  <keyword>grading</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

